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The case report by Rajagopalan and Booth demonstrates successful long-term 
LVAD support of a patient with a mechanical mitral valve. The continuous flow 
from the left atrium to the left ventricle and into the inflow of the LVAD appears to 
provide sufficient washing of the Bjork-Shiley mechanical valve surfaces and 
avoid thrombosis. The higher level of anticoagulation used in this case may not 
have been needed, and in some patients this may have complicated 
gastrointestinal bleeding.  
 
Heart valve abnormalities are common in patients with advanced stage heart 
failure who are candidates for left ventricular assist device (LVAD) support. Valve 
abnormalities during LVAD support can alter both filling and emptying of the 
device, resulting in a reduced level of cardiac support. Concurrent valvular 
procedures are now performed in approximately 20% of patients undergoing 
LVAD implantation (1, 2). Many of these patients have had prior placement of a 
prosthetic valve and are usually more ill than the average LVAD recipient at the 
time of implant, with a higher risk for postoperative complications and mortality. 
Careful consideration for handling preexisting prosthetic valves at the time of 
LVAD implant is vital for good outcome.  
 
Aortic Valve Considerations 
 
Continuous-flow LVADs unload the left ventricle and eject blood via an outflow 
graft attached to the ascending aorta throughout the entire cardiac cycle. This left 
ventricular bypass causes the aortic valve to be either closed or to have 
 
Citation: Gregoric, I. D. (2015).  
Surgical Considerations of LVAD 
Implantation in Patients with 
Prosthetic Valves. The VAD 
Journal, 1. doi: 
http://dx.doi.org/10.13023/VAD.2
015.05  
Editor-in-Chief: Maya Guglin, 
University of Kentucky 
Received: March 13, 2015 
Published: March 18, 2015 
© 2015 The Author(s).  This is an 
open access article published 
under the terms of the Creative 
Commons Attribution-
NonCommercial 4.0 International 
License 
(https://creativecommons.org/lice
nses/by-nc/4.0/), which permits 
unrestricted non-commercial use, 
distribution, and reproduction in 
any medium, provided that the 
original author(s) and the 
publication source are credited.   
Funding: Not applicable 
Competing interests: Not 
applicable  
 
 
	  
	  
	  
The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.05  Page 2 of 3 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
shortened opening time. Mechanical aortic valves are highly susceptible to 
thrombosis in this environment, and intermittent opening of the valve increases 
the risk of thromboembolism. Patients with preexisting mechanical aortic valves 
should have the valve oversewn or replaced with a bioprosthetic at time of LVAD 
implantation. The disadvantages of bioprosthetic valve use are the additional 
cardiopulmonary bypass time for placement and the possibility of leaflet fusion. A 
patch sewn to the annulus prevents the valve from functioning and there is a risk 
of subvalvular thrombus formation and embolization (3). Another potential 
disadvantage of the oversewn aortic outlet is in the case of pump stoppage; the 
depressed left ventricle would need to generate sufficient force to pump blood 
through the LVAD and its conduits, which may not be possible in some patients.  
The current recommendation by the 2013 International Society of Heart Lung 
Transplantation Guidelines for Mechanical Circulatory Support is to oversew the 
aortic valve in patients supported for bridge to transplant, and replacement of the 
mechanical valve with a bioprosthetic for those supported for destination therapy 
or those who are likely to have myocardial recovery (4). Patients presenting for 
LVAD implant with a properly functioning bioprosthetic aortic valve do not require 
surgical intervention. However, there are reports that thrombosis, pannus 
development, and complete fusion of the leaflets have occurred during LVAD 
support (5, 6). 
 
Mitral Valve Consideration 
 
The mitral valve will normally remain open due to the high flow rate into the 
LVAD. This high flow is believed to be adequate for washout and has a low risk 
of thrombosis for both mechanical and bioprosthetic valves (7). Due to the 
technical difficulty of replacing the mitral valve, and the low risk of thrombotic 
problems, current recommendations are to leave prosthetic mitral valve in place 
and consider increased anticoagulation. However, there is no evidence that 
increased anticoagulation is necessary, and some patients have done well 
without any anticoagulation with a mechanical valve in the mitral position during 
LVAD support (8). 
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